Camlin Fine Sciences · NSE: CAMLINFINE · BSE: 532834
Q1 FY21 results · Apr–Jun 2020
Camlin Fine Sciences reported revenue from operations of ₹305.74 crore (up 17.5% from Q1 FY20) and net profit of ₹20.56 crore (up 25.1% from Q1 FY20) for Q1 FY21 (Apr–Jun 2020), on a consolidated basis.
| Item | Q1 FY21 | Q1 FY20 | YoY | Q4 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 305.74 | 260.12 | +17.5% | 292.87 | +4.4% |
| Other income | 0.47 | 0.65 | −28.6% | 2.77 | −83.2% |
| Total income | 306.21 | 260.78 | +17.4% | 295.64 | +3.6% |
| Profit before tax | 31.51 | 22.68 | +38.9% | 12.71 | +148.0% |
| Net profit for the period | 20.56 | 16.43 | +25.1% | 2.05 | +902.9% |
| Attributable to shareholders of the company | 15.39 | 15.56 | −1.1% | 2.67 | +475.9% |
| EPS, basic (₹) | 1.27 | 1.28 | −0.8% | 0.22 | +477.3% |
| Net margin (%) | 6.7 | 6.3 | 0.7 |
| Item | Q1 FY21 | Q1 FY20 | YoY | Q4 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 121.17 | — | — | 139.54 | −13.2% |
| Other income | 0.99 | — | — | 15.71 | −93.7% |
| Total income | 122.16 | — | — | 155.25 | −21.3% |
| Profit before tax | 5.10 | — | — | 19.78 | −74.2% |
| Net profit for the period | 3.81 | — | — | 16.54 | −77.0% |
| EPS, basic (₹) | 0.31 | — | — | 1.36 | −77.2% |
| Net margin (%) | 3.1 | — | 11.9 |
Consolidated
- Filed with BSE
- 11 Aug 2020, 16:00 IST
- Board meeting
- 10 Aug 2020
- Period
- 01 Apr 2020 to 30 Jun 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 11 Aug 2020, 16:00 IST
- Board meeting
- 10 Aug 2020
- Period
- 01 Apr 2020 to 30 Jun 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE